Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Butler

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
In Vitro Cellular & Developmental Biology. Animal|July 9, 2010
Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissuesRita Barallon, Steven R Bauer, John Butler, et al.
Cancers|January 21, 2023
British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian CancerSudha Sundar, Andy Nordin, Jo Morrison, et al.
Nature Genetics|January 12, 2021
A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infectionCornelia Blume, Claire L Jackson, Cosma Mirella Spalluto, et al.
Nature Communications|October 27, 2022
Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardiumIvan Cokic, Shing Fai Chan, Xingmin Guan, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
The Lancet. Oncology|July 3, 2020
New approaches to cancer care in a COVID-19 worldJohn Butler, Christian Finley, Charles H Norell, et al.
Cancer Epidemiology|September 12, 2025
Chemotherapy use in ovarian cancer patients diagnosed 2012-2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based studyMatthew E Barclay, Sean McPhail, Shane A Johnson, et al.
The Lancet. Oncology|September 16, 2019
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based studyMelina Arnold, Mark J Rutherford, Aude Bardot, et al.
BMJ Oncology|July 15, 2025
Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012-2017: an ICBP population-based studyMatthew E Barclay, Sean McPhail, Shane A Johnson, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
In Vitro Cellular & Developmental Biology. Animal|July 9, 2010
Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissuesRita Barallon, Steven R Bauer, John Butler, et al.
Cancers|January 21, 2023
British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian CancerSudha Sundar, Andy Nordin, Jo Morrison, et al.
Nature Genetics|January 12, 2021
A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infectionCornelia Blume, Claire L Jackson, Cosma Mirella Spalluto, et al.
Nature Communications|October 27, 2022
Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardiumIvan Cokic, Shing Fai Chan, Xingmin Guan, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
The Lancet. Oncology|July 3, 2020
New approaches to cancer care in a COVID-19 worldJohn Butler, Christian Finley, Charles H Norell, et al.
Cancer Epidemiology|September 12, 2025
Chemotherapy use in ovarian cancer patients diagnosed 2012-2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based studyMatthew E Barclay, Sean McPhail, Shane A Johnson, et al.
The Lancet. Oncology|September 16, 2019
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based studyMelina Arnold, Mark J Rutherford, Aude Bardot, et al.
BMJ Oncology|July 15, 2025
Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012-2017: an ICBP population-based studyMatthew E Barclay, Sean McPhail, Shane A Johnson, et al.
Pageof 19